James Marken
Chief Operating Officer bei ANI PHARMACEUTICALS, INC.
Vermögen: 8 Mio $ am 31.03.2024
Profil
James G.
Marken is currently working as the Senior VP-Operations & Product Development at ANI Pharmaceuticals, Inc. He previously worked as the Vice President-Operations at ANI Pharmaceuticals, Inc. from 2007 to 2013.
Before that, he was a Plant Manager at Solvay Pharmaceuticals, Inc. Mr. Marken completed his undergraduate degree at Bemidji State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
10.04.2024 | 116 006 ( 0,55% ) | 8 Mio $ | 31.03.2024 |
Aktive Positionen von James Marken
Unternehmen | Position | Beginn |
---|---|---|
ANI PHARMACEUTICALS, INC. | Chief Operating Officer | 01.05.2016 |
Ehemalige bekannte Positionen von James Marken
Unternehmen | Position | Ende |
---|---|---|
ANI Pharmaceuticals, Inc. /Old/
ANI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come! | Chief Operating Officer | 18.07.2013 |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | Corporate Officer/Principal | - |
Ausbildung von James Marken
Bemidji State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANI PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | Health Technology |
ANI Pharmaceuticals, Inc. /Old/
ANI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come! | Health Technology |